Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:791-796

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McPherson, J. A.
Right arrow Articles by Sarembock, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McPherson, J. A.
Right arrow Articles by Sarembock, I. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:791.)
© 2001 American Heart Association, Inc.


Vascular Biology

Adenosine A2A Receptor Stimulation Reduces Inflammation and Neointimal Growth in a Murine Carotid Ligation Model

John A. McPherson; Kurt G. Barringhaus; Gregory G. Bishop; John M. Sanders; Jayson M. Rieger; Sean E. Hesselbacher; Lawrence W. Gimple; Eric R. Powers; Timothy Macdonald; Gail Sullivan; Joel Linden; Ian J. Sarembock

From the Cardiovascular Division, Department of Medicine (J.A.M., K.G.B., G.G.B, J.M.S., S.E.H., L.W.G., E.R.P., G.S., J.L., I.J.S.), the Department of Chemistry (J.M.R., T.M.), and the Department of Molecular Physiology and Biological Physics (J.L.), University of Virginia Health System, Charlottesville.

Correspondence to Ian J. Sarembock, MD, Box 158, Cardiovascular Division, University of Virginia Health Systems, Charlottesville, VA 22908. E-mail isarembock{at}virginia.edu

Abstract—Endothelial activation and leukocyte recruitment are early events in atherosclerosis and the vascular response to injury. Adenosine has anti-inflammatory effects on leukocytes and endothelial cells mediated through its A2A receptor. We tested the hypothesis that A2A activation would reduce inflammation and neointimal formation in a murine carotid ligation model. Before injury, mice were randomized to a 7-day subcutaneous infusion of a specific A2A receptor agonist (ATL-146e, 0.004 µg/kg per minute), vehicle control, ATL-146e plus ZM241385 (a selective A2A antagonist), or ZM241385 alone. Leukocyte recruitment and adhesion molecule expression were assessed at early time points, and the neointimal area was measured at 14 and 28 days after injury. Compared with control mice, ATL-146e–treated mice had significantly less neutrophil and macrophage recruitment and vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and P-selectin expression in the first 7 days after injury. Neointimal area was markedly and persistently reduced by 80% at 14 and 28 days, despite termination of ATL infusion at 7 days. ATL-146e+ZM241385–treated and ZM241385-treated animals had neointimal areas similar to those of control animals, confirming that the observed effects of ATL-146e were mediated specifically by the A2A receptor. These data demonstrate that novel stimulation of adenosine A2A receptors can inhibit early inflammatory processes that are important in neointimal formation after vascular injury.


Key Words: adenosine • restenosis • cell adhesion molecules • endothelium • leukocytes




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. W. S. Li, R. Y. K. Man, P. M. Vanhoutte, and G. P. H. Leung
Stimulation of ecto-5'-nucleotidase in human umbilical vein endothelial cells by lipopolysaccharide
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1177 - H1181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu, K. Ravid, and B. D. Smith
Major Histocompatibility Class II Transactivator Expression in Smooth Muscle Cells from A2b Adenosine Receptor Knock-out Mice: CROSS-TALK BETWEEN THE ADENOSINE AND INTERFERON-{gamma} SIGNALING
J. Biol. Chem., May 23, 2008; 283(21): 14213 - 14220.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Yang, M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid
The A2b adenosine receptor protects against vascular injury
PNAS, January 15, 2008; 105(2): 792 - 796.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Kaetsu, Y. Yamamoto, S. Sugihara, T. Matsuura, G. Igawa, K. Matsubara, O. Igawa, C. Shigemasa, and I. Hisatome
Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro
Cardiovasc Res, October 1, 2007; 76(1): 160 - 166.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller
Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3164 - H3171.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. W. Orr, R. Stockton, M. B. Simmers, J. M. Sanders, I. J. Sarembock, B. R. Blackman, and M. A. Schwartz
Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis
J. Cell Biol., February 26, 2007; 176(5): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Zernecke, K. Bidzhekov, B. Ozuyaman, L. Fraemohs, E. A. Liehn, J. M. Luscher-Firzlaff, B. Luscher, J. Schrader, and C. Weber
CD73/Ecto-5'-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation
Circulation, May 2, 2006; 113(17): 2120 - 2127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M.-C. Toufektsian, Z. Yang, K. M. Prasad, L. Overbergh, S. I. Ramos, C. Mathieu, J. Linden, and B. A. French
Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1410 - H1418.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Ralph, A. N. McEvoy, D. Kane, B. Bresnihan, O. FitzGerald, and E. P. Murphy
Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses
J. Immunol., July 1, 2005; 175(1): 555 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. W. Orr, J. M. Sanders, M. Bevard, E. Coleman, I. J. Sarembock, and M. A. Schwartz
The subendothelial extracellular matrix modulates NF-{kappa}B activation by flow: a potential role in atherosclerosis
J. Cell Biol., April 11, 2005; 169(1): 191 - 202.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. B. Reece, V. E. Laubach, C. G. Tribble, T. S. Maxey, P. I. Ellman, P. S. Warren, A. M. Schulman, J. Linden, J. A. Kern, and I. L. Kron
Adenosine A2A Receptor Agonist Improves Cardiac Dysfunction From Pulmonary Ischemia-Reperfusion Injury
Ann. Thorac. Surg., April 1, 2005; 79(4): 1189 - 1195.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. B. Reiss, M. M. Rahman, E. S. L. Chan, M. C. Montesinos, N. W. Awadallah, and B. N. Cronstein
Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages
J. Leukoc. Biol., September 1, 2004; 76(3): 727 - 734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J F Kinsel and M V Sitkovsky
Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands
Ann Rheum Dis, November 1, 2003; 62(90002): ii22 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Platts, J. Linden, and B. R. Duling
Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2360 - H2367.
[Abstract] [Full Text] [PDF]